These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16546478)

  • 1. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J; Hirano T; Fukui T; Saito K; Kageyama H; Okada K; Adachi M
    Metabolism; 2006 Apr; 55(4):478-88. PubMed ID: 16546478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing actions of angiotensin II type 1 and 2 receptors on plasma cholesterol levels in rats.
    Hirano T; Ran J; Adachi M
    J Hypertens; 2006 Jan; 24(1):103-8. PubMed ID: 16331107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic insulin infusion normalizes blood pressure and the gene expressions of angiotensin II type 1 receptor in fructose-fed rats.
    Fukui T; Hirano T; Shiraishi Y; Nagashima M; Adachi M
    Hypertens Res; 2008 Jan; 31(1):127-33. PubMed ID: 18360027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
    Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
    Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
    Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
    Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats.
    Ran J; Hirano T; Adachi M
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E955-61. PubMed ID: 15213064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olmesartan ameliorates insulin sensitivity by modulating tumor necrosis factor-alpha and cyclic AMP in skeletal muscle.
    Yamaguchi K; Ura N; Murakami H; Togashi N; Hyakukoku M; Higashiura K; Shimamoto K
    Hypertens Res; 2005 Sep; 28(9):773-8. PubMed ID: 16419651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
    Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats.
    Ran J; Hirano T; Adachi M
    J Hypertens; 2005 Aug; 23(8):1525-30. PubMed ID: 16003179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
    Igarashi M; Hirata A; Nozaki H; Kadomoto-Antsuki Y; Tominaga M
    Diabetes Res Clin Pract; 2007 Mar; 75(3):267-77. PubMed ID: 16934905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
    Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
    Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
    Hsieh PS; Tai YH; Loh CH; Shih KC; Cheng WT; Chu CH
    Metabolism; 2005 Feb; 54(2):157-64. PubMed ID: 15690308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
    Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
    Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of stunned myocardium in dogs with olmesartan, an angiotensin II type 1 receptor antagonist, is independent of type 2 receptors.
    Kano S; Satoh K; Kaneta S; Ichihara K
    Pharmacology; 2008; 82(1):22-9. PubMed ID: 18434761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.
    Erbe DV; Gartrell K; Zhang YL; Suri V; Kirincich SJ; Will S; Perreault M; Wang S; Tobin JF
    Vascul Pharmacol; 2006 Sep; 45(3):154-62. PubMed ID: 16765099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of peroxisome proliferator-activated receptor-alpha agonist on adipokines expression in rats fed with high-fat diet].
    Li Y; Huang B; Cheng H; Liang Z; Liu SY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):761-5. PubMed ID: 17260462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-alpha.
    Pérez-Matute P; Pérez-Echarri N; Martínez JA; Marti A; Moreno-Aliaga MJ
    Br J Nutr; 2007 Feb; 97(2):389-98. PubMed ID: 17298710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy.
    McLachlan KA; O'Neal D; Jenkins A; Alford FP
    Diabetes Metab Res Rev; 2006; 22(2):131-8. PubMed ID: 16170833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.